Christos Nicholoudis - Feb 8, 2024 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Signature
/s/ Nathen Fuentes, Attorney-in-Fact for Christos Nicholoudis
Stock symbol
TELO
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
3
Date filed
2/8/2024, 05:40 PM
Previous filing
Aug 21, 2023

No securities are beneficially owned.